Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 784

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease

Open access
Parsa, Afshin, Kao, W.H. Linda, Xie, Dawei, Astor, Brad C., Li, Man, Hsu, Chi-yuan, Feldman, Harold I., Parekh, Rulan S., Kusek, John W., Greene, Tom H., Fink, Jeffrey C., Anderson, Amanda H., Choi, Michael J., Wright, Jackson T., Lash, James P., Freedman, Barry I., Ojo, Akinlolu, Winkler, Cheryl A., Raj, Dominic S., Kopp, Jeffrey B., He, Jiang, Jensvold, Nancy G., Tao, Kaixiang, Lipkowitz, Michael S., Appel, Lawrence J.·2013·New England Journal of Medicine

Abstract

BACKGROUND: Among patients in the United States with chronic kidney disease, black patients are at increased risk for end-stage renal disease, as compared with white patients. METHODS: In two studies, we examined the effects of variants in the gene encoding apolipoprotein L1 (APOL1) on the progression of chronic kidney disease. In the African American Study of Kidney Disease and Hypertension (AASK), we evaluated 693 black patients with chronic kidney disease attributed to hypertension. In the Chronic Renal Insufficiency Cohort (CRIC) study, we evaluated 2955 white patients and black patients with chronic kidney disease (46% of whom had diabetes) according to whether they had 2 copies of high-risk APOL1 variants (APOL1 high-risk group) or 0 or 1 copy (APOL1 low-risk group). In the AASK study, the primary outcome was a composite of end-stage renal disease or a doubling of the serum creatinine level. In the CRIC study, the primary outcomes were the slope in the estimated glomerular filtration rate (eGFR) and the composite of end-stage renal disease or a reduction of 50% in the eGFR from baseline. RESULTS: In the AASK study, the primary outcome occurred in 58.1% of the patients in the APOL1 high-risk group and in 36.6% of those in the APOL1 low-risk group (hazard ratio in the high-risk group, 1.88; P<0.001). There was no interaction between APOL1 status and trial interventions or the presence of baseline proteinuria. In the CRIC study, black patients in the APOL1 high-risk group had a more rapid decline in the eGFR and a higher risk of the composite renal outcome than did white patients, among those with diabetes and those without diabetes (P<0.001 for all comparisons). CONCLUSIONS: Renal risk variants in APOL1 were associated with the higher rates of end-stage renal disease and progression of chronic kidney disease that were observed in black patients as compared with white patients, regardless of diabetes status. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1310345

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Cited by

See all 784

Metadata

Authors
Parsa, A., Kao, W. H. L., Xie, D., Astor, B. C., Li, M., Hsu, C.-Y., Feldman, H. I., Parekh, R. S., Kusek, J. W., Greene, T. H., Fink, J. C., Anderson, A. H., Choi, M. J., Wright, J. T., Lash, J. P., Freedman, B. I., Ojo, A., Winkler, C. A., Raj, D. S., Kopp, J. B., He, J., Jensvold, N. G., Tao, K., Lipkowitz, M. S., & Appel, L. J.
Venue
New England Journal of Medicine
Published
2013-12-05
Volume
369
Issue
23
Pages
2183-2196
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2002359955
Cited by
784
References
41
FWCI
45.74
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease. https://app.cochat.ai/papers/10.1056/nejmoa1310345
The paper
Parsa, A., Kao, W. H. L., Xie, D., Astor, B. C., Li, M., Hsu, C.-Y., Feldman, H. I., Parekh, R. S., Kusek, J. W., Greene, T. H., Fink, J. C., Anderson, A. H., Choi, M. J., Wright, J. T., Lash, J. P., Freedman, B. I., Ojo, A., Winkler, C. A., Raj, D. S., . . . Appel, L. J. (2013). APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1310345

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.